Carlo Rosa
Vermögen: 363 Mio $ am 31.05.2026
Vermögen: 363 Mio $ am 31.05.2026
Herr Carlo Rosa ist Chief Executive Officer, Executive Director & GM bei DiaSorin SpA und Director & Partner bei Sarago SRL. Er ist Mitglied des Verwaltungsrats von DiaSorin SpA, Diasorin, Inc. und Istituto Italiano di Tecnologia, Transgenic Operative Products SRL und Sarago SRL. Herr Rosa war zuvor als stellvertretender Vorsitzender bei Assobiotec, als Geschäftsführer bei DiaSorin Deutschland GmbH und als Director-Infectious Disease Business Unit bei Incstar Corp. tätig. Er erhielt seinen Bachelor-Abschluss an der Universität Turin.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DIASORIN S.P.A. 8,36 % | 28.04.2025 | 4 679 214 ( 8,36 % ) | 363 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DIASORIN S.P.A. | Vorstandsvorsitzender | 26.03.2007 |
Sarago SRL
Sarago SRL RestaurantsConsumer Services Operates restaurant | Direktor/Vorstandsmitglied | - |
Diasorin, Inc.
Diasorin, Inc. Medical SpecialtiesHealth Technology Develops and manufactures reagents for in vitro diagnostics | Direktor/Vorstandsmitglied | 15.04.2010 |
Istituto Italiano di Tecnologia
Istituto Italiano di Tecnologia Miscellaneous Commercial ServicesCommercial Services Engages in scientific research in public interest for the purpose of technological development | Direktor/Vorstandsmitglied | 01.01.2015 |
Assobiotec
Assobiotec Miscellaneous Commercial ServicesCommercial Services Operates as professional association for the development of biotechnology | Direktor/Vorstandsmitglied | 01.03.2016 |
| Unternehmen | Position | Ende |
|---|---|---|
DiaSorin Deutschland GmbH
DiaSorin Deutschland GmbH Miscellaneous Commercial ServicesCommercial Services Engages in developing, producing and selling vitro diagnostic reagents | Vorstandsvorsitzender | - |
Incstar Corp.
Incstar Corp. Medical SpecialtiesHealth Technology Develops and markets medical diagnostic tests | Corporate Officer/Principal | - |
Transgenic Operative Products SRL
Transgenic Operative Products SRL BiotechnologyHealth Technology Develops non-invasive imaging and biomarker tools | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Incstar Corp.
Incstar Corp. Medical SpecialtiesHealth Technology Develops and markets medical diagnostic tests | Health Technology |
DiaSorin SpA
DiaSorin SpA Medical SpecialtiesHealth Technology Specializes in research, production and sale of tests to identify pathogens in biological fluids | Health Technology |
Sarago SRL
Sarago SRL RestaurantsConsumer Services Operates restaurant | Consumer Services |
University of Turin
University of Turin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transgenic Operative Products SRL
Transgenic Operative Products SRL BiotechnologyHealth Technology Develops non-invasive imaging and biomarker tools | Health Technology |
Diasorin, Inc.
Diasorin, Inc. Medical SpecialtiesHealth Technology Develops and manufactures reagents for in vitro diagnostics | Health Technology |
DiaSorin Deutschland GmbH
DiaSorin Deutschland GmbH Miscellaneous Commercial ServicesCommercial Services Engages in developing, producing and selling vitro diagnostic reagents | Commercial Services |
Istituto Italiano di Tecnologia
Istituto Italiano di Tecnologia Miscellaneous Commercial ServicesCommercial Services Engages in scientific research in public interest for the purpose of technological development | Commercial Services |
Assobiotec
Assobiotec Miscellaneous Commercial ServicesCommercial Services Operates as professional association for the development of biotechnology | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen